货号:GS40693
Tagitanlimab is a humanized monoclonal antibody targeting programmed cell death protein 1 (PD-1). It binds to PD-1 on T cells, blocking interaction with PD-L1/PD-L2 ligands to restore anti-tumor immunity. It is being developed for the treatment of advanced solid tumors, including non-small cell lung cancer and esophageal carcinoma, both as monotherapy and in combination with other therapies.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯